KRTAP21-1
gene geneOn this page
Also known as KAP21.1
Summary
KRTAP21-1 (keratin associated protein 21-1, HGNC:18945) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 21-1 (Q3LI58). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link…. It is a selective cancer dependency (DepMap: 36.0% of cell lines).
Predicted to be located in cytosol.
Source: NCBI Gene 337977 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 17 total
- Cancer dependency (DepMap): dependent in 36.0% of screened cell lines
- MANE Select transcript:
NM_181619
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18945 |
| Approved symbol | KRTAP21-1 |
| Name | keratin associated protein 21-1 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP21.1 |
| Ensembl gene | ENSG00000187005 |
| Ensembl biotype | protein_coding |
| Entrez | 337977 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000335093
RefSeq mRNA: 1 — MANE Select: NM_181619
NM_181619
CCDS: CCDS13606
Canonical transcript exons
ENST00000335093 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001339229 | 30755015 | 30755428 |
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 91.09.
Top tissues by expression
103 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.09 | gold quality |
| sural nerve | UBERON:0015488 | 38.00 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| skin of abdomen | UBERON:0001416 | 27.34 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.00 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
| leukocyte | CL:0000738 | 24.80 | gold quality |
| kidney | UBERON:0002113 | 24.67 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| monocyte | CL:0000576 | 24.52 | gold quality |
| pancreas | UBERON:0001264 | 24.44 | gold quality |
| cortex of kidney | UBERON:0001225 | 24.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 36.0% of screened cell lines.
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 21-1 — Q3LI58 (reviewed: Q3LI58)
All UniProt accessions (1): Q3LI58
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
RefSeq proteins (1): NP_853650* (*=MANE)
Domains & families (InterPro)
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI58-F1 | 46.33 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 25 (showing top):
chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, WGTTNNNNNAAA_UNKNOWN, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP, GOCC_SUPRAMOLECULAR_POLYMER, TATA_01, GSE17721_CTRL_VS_LPS_1H_BMDC_UP, GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP, GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP, GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN, GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN, GSE20366_TREG_VS_TCONV_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
330 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP21-1 | KRTAP21-2 | Q3LI59 | 772 |
| KRTAP21-1 | KRTAP21-3 | Q3LHN1 | 770 |
| KRTAP21-1 | KRTAP6-3 | Q3LI67 | 717 |
| KRTAP21-1 | KRTAP20-1 | Q3LI63 | 667 |
| KRTAP21-1 | KRTAP22-1 | Q3MIV0 | 666 |
| KRTAP21-1 | KRTAP20-2 | Q3LI61 | 631 |
| KRTAP21-1 | KRTAP4-16 | G5E9R7 | 627 |
| KRTAP21-1 | KRTAP26-1 | Q6PEX3 | 624 |
| KRTAP21-1 | KRTAP6-1 | Q3LI64 | 599 |
| KRTAP21-1 | KRTAP15-1 | Q3LI76 | 599 |
| KRTAP21-1 | KRTAP19-6 | Q3LI70 | 593 |
| KRTAP21-1 | KRTAP7-1 | Q8IUC3 | 581 |
| KRTAP21-1 | KRTAP8-1 | Q8IUC2 | 571 |
| KRTAP21-1 | SCYGR1 | A0A286YEY9 | 570 |
| KRTAP21-1 | KRTAP6-2 | Q3LI66 | 506 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O14633, P02438, P04459, P05687, P05688, P08131, P08175, P0DSO2, P20730, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T750, Q5T752, Q5T754, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q8IUC1, Q8IUG1, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6
Diamond homologs: Q3LI58, Q3LI59, Q925H4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
161 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30755271:ACAG:A | donor_gain | 0.8600 |
| 21:30755272:CAGC:C | donor_gain | 0.8600 |
| 21:30755292:G:C | donor_gain | 0.8400 |
| 21:30755272:CAG:C | donor_gain | 0.8300 |
| 21:30755280:G:C | donor_gain | 0.7800 |
| 21:30755271:A:AC | donor_gain | 0.7600 |
| 21:30755272:C:CC | donor_gain | 0.7600 |
| 21:30755291:AG:A | donor_gain | 0.7400 |
| 21:30755322:G:C | donor_gain | 0.7400 |
| 21:30755321:AG:A | donor_gain | 0.6500 |
| 21:30755422:T:TA | donor_gain | 0.6500 |
| 21:30755286:T:A | donor_gain | 0.6200 |
| 21:30755346:G:C | donor_gain | 0.6000 |
| 21:30755093:TCAG:T | donor_gain | 0.5800 |
| 21:30755144:A:T | acceptor_gain | 0.5800 |
| 21:30755279:AG:A | donor_gain | 0.5700 |
| 21:30755358:G:A | donor_gain | 0.5700 |
| 21:30755268:CCCA:C | donor_gain | 0.5600 |
| 21:30755139:T:C | acceptor_gain | 0.5500 |
| 21:30755158:CTT:C | acceptor_gain | 0.5400 |
| 21:30755178:G:GT | acceptor_gain | 0.5400 |
| 21:30755179:T:TT | acceptor_gain | 0.5400 |
| 21:30755263:CCATA:C | donor_loss | 0.5400 |
| 21:30755264:CATA:C | donor_loss | 0.5400 |
| 21:30755265:ATAC:A | donor_loss | 0.5400 |
| 21:30755266:TACCC:T | donor_loss | 0.5400 |
| 21:30755267:A:C | donor_loss | 0.5400 |
| 21:30755268:C:CG | donor_loss | 0.5400 |
| 21:30755162:T:TG | acceptor_gain | 0.5300 |
| 21:30755267:A:AC | donor_gain | 0.5300 |
AlphaMissense
491 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30755163:A:C | F72L | 0.712 |
| 21:30755163:A:T | F72L | 0.712 |
| 21:30755165:A:G | F72L | 0.712 |
| 21:30755253:A:C | F42L | 0.677 |
| 21:30755253:A:T | F42L | 0.677 |
| 21:30755255:A:G | F42L | 0.677 |
| 21:30755227:C:T | G51E | 0.664 |
| 21:30755144:A:G | C79R | 0.644 |
| 21:30755287:C:T | G31E | 0.626 |
| 21:30755142:G:C | C79W | 0.594 |
| 21:30755209:C:T | G57E | 0.593 |
| 21:30755169:A:C | F70L | 0.575 |
| 21:30755169:A:T | F70L | 0.575 |
| 21:30755171:A:G | F70L | 0.575 |
dbSNP variants (sampled 300 via entrez): RS1000342267 (21:30754777 A>G), RS1001331366 (21:30757417 G>A), RS1003829725 (21:30755714 A>C,G,T), RS1003873403 (21:30755661 G>A), RS1005494223 (21:30756778 A>T), RS1008404220 (21:30755015 G>A,C), RS1010729262 (21:30755760 CT>C,CTT), RS1010786635 (21:30756088 C>G,T), RS1014932360 (21:30756771 G>A,C), RS1017162634 (21:30756788 T>C), RS1019388224 (21:30756117 A>T), RS1019390557 (21:30755030 G>A,C), RS1019714628 (21:30754732 G>C), RS1020455534 (21:30754685 CATT>C), RS1021739084 (21:30755765 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Bortezomib | increases expression, increases response to substance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Endosulfan | decreases reaction, increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases reaction, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.